Literature DB >> 2508659

Analysis of autoantibody reactivity and common idiotype PR4 expression of myeloma proteins.

R A Watts1, W Williams, S Le Page, A Norden, A Soltys, G Swana, I Addison, F C Hay, D A Isenberg.   

Abstract

Sera from 75 patients with monoclonal gammopathies and with no clinical evidence of autoimmune disease have been screened for a wide range of autoreactivity including binding to DNA, cardiolipin, extractable nuclear antigen (ENA), rheumatoid factor activity and the presence of the common anti-DNA antibody idiotype PR4. The sera of 17/75 (23%) patients possessed autoreactivity: six were positive for anti-DNA activity, two had anticardiolipin activity and the PR4 ID was found in two sera (both of which possessed anti-DNA activity). Antibodies to ENA were found in one serum (anti-Ro) and anti-organ-specific antibodies in five. Using iso-electric focusing and immunoblotting we have shown that the PR4 ID and DNA binding activity are carried on the paraprotein and not on some other serum constituent. The IgG subclass distribution of 55 IgG paraproteins has also been investigated. The majority of IgG paraproteins belong to IgG1 subclass (55%), with the others, being IgG2 (4%), IgG3 (9%) and IgG4 (27%). In this study we have shown that sera from myeloma patients frequently possess autoreactivity, and that in many cases this can be attributed to the paraprotein.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2508659     DOI: 10.1016/s0896-8411(89)80007-1

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  10 in total

Review 1.  Hypergammaglobulinaemia and autoimmune rheumatic diseases.

Authors:  M R Ehrenstein; D A Isenberg
Journal:  Ann Rheum Dis       Date:  1992-11       Impact factor: 19.103

Review 2.  Autoantibodies and antibacterial antibodies: from both sides now.

Authors:  R A Watts; D A Isenberg
Journal:  Ann Rheum Dis       Date:  1990-12       Impact factor: 19.103

3.  A human fetal monoclonal DNA-binding antibody shares idiotypes with fetal and adult murine monoclonal DNA-binding antibodies.

Authors:  R A Watts; C T Ravirajan; N A Staines; D A Isenberg
Journal:  Immunology       Date:  1990-03       Impact factor: 7.397

4.  Serological and genetic characterization of a human monoclonal immunoglobulin G anti-DNA idiotype.

Authors:  M R Ehrenstein; C M Longhurst; D S Latchman; D A Isenberg
Journal:  J Clin Invest       Date:  1994-04       Impact factor: 14.808

5.  Production of human monoclonal antibodies to myeloperoxidase.

Authors:  M R Ehrenstein; B Leaker; D Isenberg; G Cambridge
Journal:  Immunology       Date:  1992-12       Impact factor: 7.397

6.  Production and analysis of IgG monoclonal anti-DNA antibodies from systemic lupus erythematosus (SLE) patients.

Authors:  M Ehrenstein; C Longhurst; D A Isenberg
Journal:  Clin Exp Immunol       Date:  1993-04       Impact factor: 4.330

7.  Phospholipid binding specificities and idiotype expression of hybridoma derived monoclonal autoantibodies from splenic cells of patients with systemic lupus erythematosus.

Authors:  C T Ravirajan; I Harmer; T McNally; A Hohmann; C G Mackworth-Young; D A Isenberg
Journal:  Ann Rheum Dis       Date:  1995-06       Impact factor: 19.103

8.  Detection of human and murine common idiotypes of DNA antibodies in tissues and sera of patients with autoimmune diseases.

Authors:  R A Watts; C T Ravirajan; L S Wilkinson; W Williams; M Griffiths; D Butcher; A T Horsfall; N A Staines; D A Isenberg
Journal:  Clin Exp Immunol       Date:  1991-02       Impact factor: 4.330

9.  Increased thromboembolic incidence in anti-cardiolipin-positive patients with malignancy.

Authors:  E Zuckerman; E Toubi; T D Golan; T Rosenvald-Zuckerman; E Sabo; Z Shmuel; D Yeshurun
Journal:  Br J Cancer       Date:  1995-08       Impact factor: 7.640

10.  Heavy chain deposition disease presenting with raised anti-GBM antibody levels; a case report.

Authors:  Michael Turner; Anna Crawford; Claire Winterbottom; Oliver Flossmann; Bassam Alchi; Maria Soares; Umanath Bhandary
Journal:  BMC Nephrol       Date:  2020-05-12       Impact factor: 2.388

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.